Southport Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $648K | Hold |
15,000
| – | – | 3.16% | 13 |
|
2025
Q1 | $519K | Hold |
15,000
| – | – | 2.24% | 17 |
|
2024
Q4 | $412K | Hold |
15,000
| – | – | 1.49% | 28 |
|
2024
Q3 | $382K | Hold |
15,000
| – | – | 1.42% | 27 |
|
2024
Q2 | $380K | Hold |
15,000
| – | – | 1.7% | 19 |
|
2024
Q1 | $464K | Hold |
15,000
| – | – | 1.71% | 23 |
|
2023
Q4 | $606K | Hold |
15,000
| – | – | 2.61% | 16 |
|
2023
Q3 | $396K | Hold |
15,000
| – | – | 2.15% | 17 |
|
2023
Q2 | $258K | Buy |
+15,000
| New | +$258K | 1.41% | 24 |
|
2021
Q3 | – | Sell |
-12,000
| Closed | -$732K | – | 29 |
|
2021
Q2 | $732K | Hold |
12,000
| – | – | 2.47% | 18 |
|
2021
Q1 | $739K | Buy |
+12,000
| New | +$739K | 2.74% | 17 |
|